LONG-TERM MAINTENANCE OF IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 48-WEEK RESULTS OF THE RAPID-AXSPA STUDY

被引：1

作者：

Sieper, J. ^{[1
]}

Kivitz, A. ^{[2
]}

van Tubergen, A. ^{[3
]}

Deodhar, A. ^{[4
]}

Coteur, G. ^{[5
]}

Singh, P. ^{[6
]}

Landewe, R. ^{[7
]}

机构：

[1] Univ Hosp Charite, Berlin, Germany

[2] Altoona Ctr Clin Res, Duncansville, PA USA

[3] Maastricht Univ, Med Ctr, Maastricht, Netherlands

[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[5] UCB Pharma, Brussels, Belgium

[6] UCB Pharma, Monheim, Germany

[7] Amsterdam & Atrium Med Ctr, Heerlen, Netherlands

来源：

关键词：

D O I：

10.1016/j.jval.2013.08.1523

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A569 / A569

页数：1